Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Other Operating Expenses (2017 - 2019)

Mimedx's Other Operating Expenses history spans 3 years, with the latest figure at $2.3 million for Q4 2019.

  • For Q4 2019, Other Operating Expenses rose 841.35% year-over-year to $2.3 million; the TTM value through Sep 2020 reached $2.3 million, up 841.35%, while the annual FY2020 figure was -$8.2 million, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2019 was $2.3 million at Mimedx, up from -$312000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2.3 million in Q4 2019 and bottomed at -$1.0 million in Q3 2017.
  • The 3-year median for Other Operating Expenses is -$312000.0 (2018), against an average of $317666.7.
  • The largest YoY upside for Other Operating Expenses was 841.35% in 2019 against a maximum downside of 841.35% in 2019.
  • A 3-year view of Other Operating Expenses shows it stood at -$1.0 million in 2017, then soared by 70.23% to -$312000.0 in 2018, then soared by 841.35% to $2.3 million in 2019.
  • Per Business Quant, the three most recent readings for MDXG's Other Operating Expenses are $2.3 million (Q4 2019), -$312000.0 (Q4 2018), and -$1.0 million (Q3 2017).